Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo

被引:0
|
作者
Lamensdorf, I
Youdim, MBH
Finberg, JPM
机构
关键词
clorgyline; deprenyl; TVP-1012; dopamine; microdialysis; monoamine oxidase;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute inhibition of monoamine oxidase B (MAO-B) in the rat does not affect striatal dopamine (DA) metabolism, but chronic MAO-B inhibition with deprenyl has been reported to increase the release of striatal DA, as shown using in vitro techniques. To see whether chronic MAO-B inhibition also causes an increase in DA release in vivo, rats were treated for 21 days with either deprenyl (0.25 mg/kg), TVP-1012 [R(+)-N-propargyl-1-aminoindan mesylate; 0.05 mg/kg], an irreversible inhibitor of MAO-B that is not metabolized to amphetamines, clorgyline (0.2 mg/kg), or saline (all doses once daily by subcutaneous injection). Concentric 4-mm-long microdialysis probes were implanted in the left striatum under pentobarbital/chloral hydrate anesthesia on day 21, and microdialysate DA, 3,4,dihydroxyacetic acid (DOPAC), and 4-hydroxy-3-methoxyphenyl acetic acid (HVA) were determined in the conscious animals on day 22. Baseline levels of DA were as follows: control, 0.34 +/- 0.04 (n = 13); deprenyl, 0.88 +/- 0.10 (n = 8, p < 0.01); TVP-1012, 0.94 +/- 0.20 (n = 7, p < 0.01); clorgyline, 0.90 +/- 0.12 (n = 7, p < 0.01) pmol/20 min. Levels of DOPAC and HVA were reduced only in the clorgyline-treated group. The incremental release of DA induced by depolarizing concentration of K+ (100 mM bolus of KCl in perfusate) was significantly greater in clorgyline- and deprenyl-treated rats and elevated (nonsignificantly) in TVP-1012-treated rats. Chronic treatment with the MAO-B inhibitors reduced striatal MAO-B activity by 90%, with 15% (TVP-1012) or 40% (deprenyl) inhibition of MAO-A. Clorgyline inhibited MAO-A by 95%, with 30% inhibition of MAO-B. A single dose of deprenyl (0.25 mg/kg, 24 h before microdialysis) had no significant effect on striatal efflux of DA. The results show that DA metabolism was reduced only by clorgyline, whereas neuronal release of DA was enhanced by both MAO-A and MAO-B inhibitors on chronic administration. The enhanced DA release by chronic MAO-B inhibition does not appear to be dependent on production of amphetamine-like metabolites of the inhibitor. Possible mechanisms for the release-enhancing effect of the MAO-B inhibitors include elevation in levels of endogenous beta-phenylethylamine, or an inhibition of DA reuptake, which develops only on chronic administration, because both deprenyl and TVP-1012 have only very weak effects on amine uptake in acute experiments.
引用
收藏
页码:1532 / 1539
页数:8
相关论文
共 50 条
  • [41] Community and long-term care management of Parkinson's disease in the elderly - Focus on monoamine oxidase type B inhibitors
    Chen, Jack J.
    Fernandez, Hubert H.
    DRUGS & AGING, 2007, 24 (08) : 663 - 680
  • [42] INFLUENCE OF MONOAMINE-OXIDASE INHIBITION ON THE RELEASE OF H-3-DOPAMINE ELICITED BY POTASSIUM AND BY AMPHETAMINE FROM THE RAT SUBSTANTIA NIGRA AND CORPUS STRIATUM
    ARBILLA, S
    LANGER, SZ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 311 (01) : 45 - 52
  • [43] Long-term monitoring of extracellular dopamine concentration in the rat striatum by a repeated microdialysis procedure
    MartinFardon, R
    Sandillon, F
    Thibault, J
    Privat, A
    Vignon, J
    JOURNAL OF NEUROSCIENCE METHODS, 1997, 72 (02) : 123 - 135
  • [44] RELEASE OF ENDOGENOUS DOPAMINE FROM RAT ISOLATED STRIATUM - EFFECT OF CLORGYLINE AND (-)-DEPRENYL
    HARSING, LG
    VIZI, ES
    BRITISH JOURNAL OF PHARMACOLOGY, 1984, 83 (03) : 741 - 749
  • [45] EFFECT OF COLLAGENASE ON RELEASE OF DOPAMINE AND ACETYLCHOLINE FROM SLICES OF RAT CORPUS STRIATUM
    NOWYCKY, MC
    SGARAGLI, GP
    COOPER, JR
    ROTH, RH
    JOURNAL OF NEUROCHEMISTRY, 1975, 24 (06) : 1279 - 1281
  • [46] EFFECT OF PROLACTIN ON DOPAMINE RELEASE FROM RAT STRIATUM AND MEDIAL BASAL HYPOTHALAMUS
    PERKINS, NA
    WESTFALL, TC
    NEUROSCIENCE, 1978, 3 (01) : 59 - 63
  • [47] Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised
    Gray, Richard
    Ives, Natalie
    Rick, Caroline
    Patel, Smitaa
    Gray, Alastair
    Jenkinson, Crispin
    McIntosh, Emma
    Wheatley, Keith
    Williams, Adrian
    Clarke, Carl E.
    Sandercock, P.
    Baigent, C.
    Crome, P.
    Williams, A.
    Abbott, R.
    Baker, M.
    Castleton, B.
    Clarke, C. E.
    Counsell, C.
    Deb, A. K.
    Fairweather, S.
    Fitzpatrick, R.
    Gray, A.
    Ives, N.
    Jenkinson, C.
    MacPhee, G.
    Malone, T.
    Mant, D.
    McIntosh, E.
    Ming, A.
    Morrish, P.
    Ohri, P.
    Pearce, V.
    Wood, B.
    Worth, P.
    Au, P.
    Boodell, T.
    Cheed, V.
    Clarke, C. E.
    Daniels, J.
    Dowling, F.
    Edmondson, A.
    Gray, R.
    Hawker, R.
    Herd, C.
    Hilken, N.
    Ives, N.
    Kaur, S.
    Ottridge, R.
    Patel, S.
    LANCET, 2014, 384 (9949): : 1196 - 1205
  • [48] LONG-TERM EFFECT OF OVARIECTOMY ON DOPAMINE-STIMULATED ADENYLATE-CYCLASE IN RAT STRIATUM AND NUCLEUS ACCUMBENS
    KUMAKURA, K
    HOFFMAN, M
    COCCHI, D
    TRABUCCHI, M
    SPANO, PF
    MULLER, EE
    PSYCHOPHARMACOLOGY, 1979, 61 (01) : 13 - 16
  • [49] MPP+-evoked hydroxyl radical formation in the rat striatum in vivo is altered by the monoamine oxidase inhibitors selegiline and clorgyline, but not pargyline
    Rose, S
    Hindmarsh, JG
    Jenner, P
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U8 - U8
  • [50] Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration
    Urichuk, LJ
    Allison, K
    Holt, A
    Greenshaw, AJ
    Baker, GB
    JOURNAL OF AFFECTIVE DISORDERS, 2000, 58 (02) : 135 - 144